Quantcast

Latest Lewy body Stories

2010-10-14 05:00:00

PRINCETON, N.J., Oct. 14 /PRNewswire/ -- GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced that DaTSCAN(TM) (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue...

2010-09-16 08:10:00

(Ivanhoe Newswire) "“ Becoming forgetful may be more than just a function of old age. According to a new study, the same brain lesions that are associated with dementia are responsible for mild memory loss in old age. "It appears these brain lesions have a much greater impact on memory function in old age than we previously thought," study author Robert S. Wilson, PhD, at Rush University Medical Center in Chicago, was quoted as saying. "Our results challenge the concept of normal memory...

2010-09-10 12:09:20

Yeast could be a powerful ally in the discovery of new therapeutic drugs to treat Parkinson's disease says a scientist presenting his work at the Society for General Microbiology's autumn meeting in Nottingham today. Dr Tiago Fleming Outeiro from the Instituto de Medicina Molecular in Lisbon, Portugal describes how his group is slowly uncovering the molecular basis of Parkinson's disease by studying the associated human protein in yeast cells. Parkinson's disease is a neurodegenerative...

2010-05-11 09:00:00

NEW YORK, May 11 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and the Lewy Body Dementia Association (LBDA) announced today the recipient of their first partnership research award through the Lewy Body Dementia Biomarker Research Program. The goal of the program is to catalyze the discovery of innovative biomarkers that aid in early diagnosis, detection and disease monitoring of Lewy body dementias (LBD). The ADDF/LBDA program awarded $125,000 to one...

2010-04-23 10:44:00

NEW YORK, April 23 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today announced more than $3 million in previously unannounced awards ending the first quarter of 2010. The funded projects complement the Foundation's annually occurring Pipeline Programs and Critical Challenges in Parkinson's Disease initiatives, which aim to accelerate PD therapeutic development. Many of the 17 different projects announced today provide additional funding to advance...

2010-03-02 14:15:00

NEW YORK, March 2 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research announced up to $5.75 million in total funding available under its three 2010 Critical Challenges. Each year the Foundation tailors specific Challenges to advance one or more of its key research priorities in PD drug development: forging new strategies to define Parkinson's disease and its progression, alter disease course, reduce symptoms and complications of treatment to increase quality...

2010-01-19 11:57:22

Cognitive fluctuations, or episodes when train of thought temporarily is lost, are more likely to occur in older persons who are developing Alzheimer's disease than in their healthy peers, according to scientists at Washington University School of Medicine in St. Louis. Cognitive fluctuations include excessive daytime sleepiness, staring into space and disorganized or illogical thinking. "If you have these lapses, they don't by themselves mean that you have Alzheimer's," says senior author...

2009-12-28 16:59:32

FINDINGS: Several structurally similar small molecules appear capable of protecting cells from alpha-synuclein toxicity, a hallmark of Parkinson's disease. RELEVANCE: Parkinson's disease is a neurodegenerative disorder characterized by tremors, muscle rigidity, and slowed movements. There is currently no cure for the disease, and current Parkinson's therapies only address disease symptoms, not the disease's cellular cause. Small molecules found to protect cells in multiple models of...

2009-12-15 13:00:00

NEW YORK, Dec. 15 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation announced $1.7 million in funding to drive new and continuing Parkinson's research projects at the Banner Sun Health Research Institute and Mayo Clinic Arizona, sites of the Arizona Parkinson's Disease Consortium. Of the total funding, $1.1 million represents renewed funding for directed projects led by principal investigators Charles Adler, MD, PhD, at Mayo Clinic Arizona and Thomas Beach, MD, PhD, at Banner Sun...

2009-10-13 10:47:19

Both genetic and pathologic data indicate a role for the neuronal protein alpha-synuclein in Parkinson disease. Previous studies have indicated that phosphorylation of alpha-synuclein at amino acid 129 (Ser129) is a key event in alpha-synuclein"“mediated nerve cell toxicity. However, Mel Feany and colleagues, at Brigham and Women's Hospital, Boston, have now identified a counterbalancing role in nerve cell protection for phosphorylation of alpha-synuclein amino acid 125 (Tyr125). In the...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related